Relationship between the thromboxane A2 receptor gene and susceptibility to cerebral infarction

Hypertension Research

Volumn 29, Issue 9, 2006, Pages 665-671

  Kaneko, Yoshiyuki ^a   Nakayama, Tomohiro ^a   Saito, Kosuke ^a,b   Morita, Akihiko ^a   Sato, Ichiro ^a   Maruyama, Aya ^a   Soma, Masayoshi ^a   Takahashi, Teruyuki ^c   Sato, Naoyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c NIHON UNIVERSITY   (Japan)

Author keywords

Case control studies; Cerebral infarction; Haplotypes; Single nucleotide polymorphism; Thromboxane A2 receptors

Indexed keywords

THROMBOXANE A2 RECEPTOR;

AGED; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOMINANT GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBRAL INFARCTION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;

EID: 33750206499     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.665     Document Type: Article

References (28)

1. Hassan A, Markus HS: Genetics and ischaemic stroke. Brain 2000; 123: 1784-1812.
2. Gorelick PB, Sacco RL, Smith DB, et al: Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999; 281: 1112-1120.
3. Yamagishi K, Iso H, Kitamura A, et al: Smoking raises the risk of total and ischemic strokes in hypertensive men. Hypertens Res 2003; 26: 209-217.
4. Coyle AT, Miggin SM, Kinsella BT: Characterization of the 5′ untranslated region of alpha and beta isoforms of the human thromboxane A2 receptor (TP). Differential promoter utilization by the TP isoforms. Eur J Biochem 2002; 269: 4058-4073.
5. Nusing RM, Hirata M, Kakizuka A, Eki T, Ozawa K, Narumiya S: Characterization and chromosomal mapping of the human thromboxane A2 receptor gene. J Biol Chem 1993; 268: 25253-25259.
6. 2 receptor protein. J Biol Chem 2002; 277: 16791-16797.
7. Huang JS, Ramamurthy SK, Lin X, Le Breton GC: Cell signalling through thromboxane A2 receptors. Cell Signal 2004; 16: 521-533.
8. Aoi N, Soma M, Nakayama T, et al: Variable number of tandem repeat of the 5′-flanking region of Type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004; 27: 711-716.
9. Baird PN, Richardson AJ, Craig JE, Mackey DA, Rochtchma E, Mitchell P: Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study. Clin Exp Ophthalmol 2004; 32: 518-522.
10. Nakayama T, Soma M, Kanmatsuse K, Kokubun S: The microsatellite alleles on chromosome 1 associated with essential hypertension and blood pressure levels. J Hum Hypertens 2004; 18: 823-828.
11. Nakayama T, Soma M, Sato N, et al: An association study in essential hypertension using functional polymorphisms in lymphotoxin-α gene. Am J Hypertens 2004; 17: 1045-1049.
12. Maruyama A, Nakayama T, Sato N, Mizutani Y, Furuya K, Yamamoto T: Association study using single nucleotide polymorphisms in the estrogen receptor β (ESR2) gene for preeclampsia. Hypertens Res 2004; 27: 903-909.
13. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from in complete data via the EM algorithm. J R Stat Soc 1977; 39: 1-22.
14. Kobayashi Y, Nakayama T, Sato N, et al: Haplotype-based case-control study of adrenomedullin genes on proteinuria in the subjects with essential hypertension. Hypertens Res 2005; 28: 229-236.
15. Nakayama T, Soma M, Rahmutula D, Izumi Y, Kanmatsuse K: Nonsense mutation of prostacyclin synthase gene in a family. Lancet 1997; 349: 1887-1888.
16. Nakayama T, Soma M, Rehemudula D, et al: Association of 5′ upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am J Hypertens 2000; 13: 1263-1267.
17. Unoki M, Furuta S, Onouchi Y, et al: Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum Genet 2000; 106: 440-446.
18. Boehringer S, Epplen JT, Krawczak M: Genetic association studies of bronchial asthma - a need for Bonferroni correction? Hum Genet 2000; 107: 197.
19. Nyholt DR: Genetic case-control association studies - correcting for multiple testing. Hum Genet 2001; 109: 564-567.
20. Hirata T, Kakizuka A, Ushikubi F, Fuse I, Okuma M, Narumiya S: Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 1994; 94: 1662-1667.
21. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM: Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 2004; 43: 364-369.
22. Thomas DW, Mannon RB, Mannon PJ, et al: Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 1998; 102: 1994-2001.
23. Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Konta A, Takamatsu S: Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. Acta Neurol Scand 1991; 83: 99-102.
24. Koudstaal PJ, Ciabattoni G, van Gijn J, et al: Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke 1993; 24: 219-223.
25. Imamura T, Kiguchi S, Kobayashi K, Ichikawa K, Yamazaki Y, Kojima M: Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger. Arzneimittelforschung 2003; 53: 688-694.
26. Cambria-Kiely JA, Gandhi PJ: Aspirin resistance and genetic polymorphisms. J Thromb Thrombolysis 2002; 14: 51-58.
27. Schork NJ, Fallin D, Lanchbury JS: Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000; 58: 250-264.
28. Morris RW, Kaplan NL: On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-233.